Spectris plc (SXS: LSE) (“Spectris”) has acquired Micromeritics Instrument Corporation (“Micromeritics”) for an upfront consideration of $630 million (£485 million) plus a deferred element up to $53 million (£41 million) based on agreed financial performance metrics in 2024 and 2025.

Headquartered in Norcross, Georgia, with 470 employees, Micromeritics is the world leader in analytical instrumentation for the physical characterization of particles, powders, and porous materials across research, product development, and quality control. Micromeritics generated sales of $117 million (£90 million) and EBIT of $30.5 million (£23.5 million) during the full year ended 31 December 2023.

This acquisition is strongly aligned with Spectris’ Strategy for Sustainable Growth. Together with Malvern Panalytical, the combination will create the leading particle characterization business for advanced materials analysis, with a highly differentiated and fully integrated offering.

The addition of Micromeritics’ technologies alongside Malvern Panalytical’s capabilities – encompassing particle distribution, particle count and zeta potential – will enable the comprehensive characterization of particles by detailing their size, count, surface properties and behavior, thus supporting the entire customer workflow from R&D to QC/QA applications.

With highly complementary product portfolios, the combination will also strengthen Spectris’ offering in the rapidly growing, clean tech markets and will deliver significant synergies.

EC M&A acted as exclusive financial advisor to Spectris on this transaction. This represents the 12th transaction EC M&A executed on behalf of Spectris.